نتائج البحث 381-390 من 23640 لعملية البحث عن B cell lymphomas
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Testing the Addition of an Anti-cancer ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. International Registry for Men With ...
... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...
Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies ...
CAR-T cell therapy, B-cell lymphoma, Lymphoma, Diffuse large b-cell lymphoma, Non-Hodgkin lymphoma, T-cell lymphoma, Cu...taneous t-cell lymphoma, Small ...
... cell lymphoma, Small lymphocytic lymphoma, Follicular lymphoma, Hodgkin lymphoma, Cutaneous b-cell lymphoma, Primary mediastinal large B-cell lymphoma. إظهار ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
... B cell lymphoma (DLBCL) subjects who failed at ... cells in hopes of increasing immune response and protecting against breast cancer. ... Onvansertib is a drug that ...
... Cell Lung Cancer. MC230818 Understanding the mechanisms of clonal and ... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.